Trial Outcomes & Findings for Therapy Cool Path Ablate VT (NCT NCT00925522)
NCT ID: NCT00925522
Last Updated: 2019-04-17
Results Overview
Recruitment status
TERMINATED
Study phase
NA
Target enrollment
20 participants
Primary outcome timeframe
7 days
Results posted on
2019-04-17
Participant Flow
Patients with atrial flutter are evaluated by ablation doctor in the EP clinic and assessed for possibility of meeting other inclusion criteria.
This is a non-randomized study.
Participant milestones
| Measure |
Therapy Cool Path Duo Cardiac Ablation System
Therapy Cool Path Duo Cardiac Ablation System: Consists of following three system components:
A flexible, insulated 7F all braided catheter that contains an internal lumen connected to 12 open conduits at the 4mm tip electrode for infusion of heparinized saline during radiofrequency ablation; records intracardiac electrograms and can be utilized for cardiac simulation during diagnostic electrophysiologic studies/evaluation.
The 1500T9-VT generator is a microprocessor-controlled device that produces a continuous unmodulated radiofrequency (RF) output of 485 kHz. The Generator will be used in Temperature Control mode only. The catheter delivers the RF power from the generator in a monopolar mode between its distal electrode (tip electrode) and a large indifferent electrode.
The Cool Point ™ Irrigation Pump and Cool Point™ Tubing Set is an external volumetric pump that is intended for use in administration of general I.V. fluids to patient's vascular system through the cat
|
|---|---|
|
Overall Study
STARTED
|
20
|
|
Overall Study
COMPLETED
|
0
|
|
Overall Study
NOT COMPLETED
|
20
|
Reasons for withdrawal
| Measure |
Therapy Cool Path Duo Cardiac Ablation System
Therapy Cool Path Duo Cardiac Ablation System: Consists of following three system components:
A flexible, insulated 7F all braided catheter that contains an internal lumen connected to 12 open conduits at the 4mm tip electrode for infusion of heparinized saline during radiofrequency ablation; records intracardiac electrograms and can be utilized for cardiac simulation during diagnostic electrophysiologic studies/evaluation.
The 1500T9-VT generator is a microprocessor-controlled device that produces a continuous unmodulated radiofrequency (RF) output of 485 kHz. The Generator will be used in Temperature Control mode only. The catheter delivers the RF power from the generator in a monopolar mode between its distal electrode (tip electrode) and a large indifferent electrode.
The Cool Point ™ Irrigation Pump and Cool Point™ Tubing Set is an external volumetric pump that is intended for use in administration of general I.V. fluids to patient's vascular system through the cat
|
|---|---|
|
Overall Study
study closed -- business decision
|
20
|
Baseline Characteristics
Therapy Cool Path Ablate VT
Baseline characteristics by cohort
| Measure |
Therapy Cool Path Duo Cardiac Ablation System
n=20 Participants
Therapy Cool Path Duo Cardiac Ablation System: Consists three system components:
A flexible, insulated 7F all braided catheter that contains an internal lumen connected to 12 open conduits at the 4mm tip electrode for infusion of heparinized saline during radiofrequency ablation; records intracardiac electrograms and can be utilized for cardiac simulation during diagnostic electrophysiologic studies/evaluation.
The 1500T9-VT generator is a microprocessor-controlled device that produces a continuous unmodulated radiofrequency (RF) output of 485 kHz. The Generator will be used in Temperature Control mode only. The catheter delivers the RF power from the generator in a monopolar mode between its distal electrode (tip electrode) and a large indifferent electrode.
The Cool Point ™ Irrigation Pump and Cool Point™ Tubing Set is an external volumetric pump that is intended for use in administration of general I.V. fluids.
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
15 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
5 Participants
n=5 Participants
|
|
Age, Continuous
|
66.8 years
STANDARD_DEVIATION 10.5 • n=5 Participants
|
|
Sex: Female, Male
Female
|
0 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
20 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
20 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 7 daysOutcome measures
| Measure |
Therapy Cool Path Duo Catheter
n=20 Participants
All patients received RF (radio frequency) therapy from ablation catheter.
|
|---|---|
|
Primary Safety is Defined as the Incidence of Intra-procedural, Acute or Sub-chronic, Serious Cardiac Adverse Events, up to 7 Days Post-procedure.
|
7 participants
|
Adverse Events
Therapy Cool Path Duo Cardiac Ablation System
Serious events: 7 serious events
Other events: 16 other events
Deaths: 0 deaths
Serious adverse events
| Measure |
Therapy Cool Path Duo Cardiac Ablation System
n=20 participants at risk
Therapy Cool Path Duo Cardiac Ablation System: Consists of:
A flexible, insulated 7F all braided catheter that contains an internal lumen connected to 12 open conduits at the 4mm tip electrode for infusion of heparinized saline during radiofrequency ablation; records intracardiac electrograms and can be utilized for cardiac simulation during diagnostic electrophysiologic studies/evaluation.
The 1500T9-VT generator is a microprocessor-controlled device that produces a continuous unmodulated radiofrequency (RF) output of 485 kHz. The Generator will be used in Temperature Control mode only. The catheter delivers the RF power from the generator in a monopolar mode between its distal electrode (tip electrode) and a large indifferent electrode.
The Cool Point ™ Irrigation Pump and Cool Point™ Tubing Set is an external volumetric pump that is intended for use in administration of general I.V. fluids to patient's vascular system through the catheter in the hospital environment.
|
|---|---|
|
Cardiac disorders
Arrhythmia(s) including AFL, AF or VT
|
25.0%
5/20 • Number of events 5 • 6 months
Definition of AEs and SAEs per clinicaltrials.gov were used
|
|
Cardiac disorders
Congestive Heart Failure
|
5.0%
1/20 • Number of events 1 • 6 months
Definition of AEs and SAEs per clinicaltrials.gov were used
|
|
Cardiac disorders
Hypotension
|
5.0%
1/20 • Number of events 1 • 6 months
Definition of AEs and SAEs per clinicaltrials.gov were used
|
|
Cardiac disorders
Cardiac Effusion without Tamponade
|
5.0%
1/20 • Number of events 1 • 6 months
Definition of AEs and SAEs per clinicaltrials.gov were used
|
|
Cardiac disorders
Cardiac Effusion with Tamponade
|
10.0%
2/20 • Number of events 2 • 6 months
Definition of AEs and SAEs per clinicaltrials.gov were used
|
Other adverse events
| Measure |
Therapy Cool Path Duo Cardiac Ablation System
n=20 participants at risk
Therapy Cool Path Duo Cardiac Ablation System: Consists of:
A flexible, insulated 7F all braided catheter that contains an internal lumen connected to 12 open conduits at the 4mm tip electrode for infusion of heparinized saline during radiofrequency ablation; records intracardiac electrograms and can be utilized for cardiac simulation during diagnostic electrophysiologic studies/evaluation.
The 1500T9-VT generator is a microprocessor-controlled device that produces a continuous unmodulated radiofrequency (RF) output of 485 kHz. The Generator will be used in Temperature Control mode only. The catheter delivers the RF power from the generator in a monopolar mode between its distal electrode (tip electrode) and a large indifferent electrode.
The Cool Point ™ Irrigation Pump and Cool Point™ Tubing Set is an external volumetric pump that is intended for use in administration of general I.V. fluids to patient's vascular system through the catheter in the hospital environment.
|
|---|---|
|
Cardiac disorders
Hypotension
|
15.0%
3/20 • Number of events 3 • 6 months
Definition of AEs and SAEs per clinicaltrials.gov were used
|
|
Cardiac disorders
Hypertension
|
15.0%
3/20 • Number of events 3 • 6 months
Definition of AEs and SAEs per clinicaltrials.gov were used
|
|
Cardiac disorders
Arrythmia
|
10.0%
2/20 • Number of events 2 • 6 months
Definition of AEs and SAEs per clinicaltrials.gov were used
|
|
Blood and lymphatic system disorders
Infection
|
5.0%
1/20 • Number of events 1 • 6 months
Definition of AEs and SAEs per clinicaltrials.gov were used
|
|
Cardiac disorders
Chest Pains Palpitations
|
10.0%
2/20 • Number of events 3 • 6 months
Definition of AEs and SAEs per clinicaltrials.gov were used
|
|
Psychiatric disorders
Anxiety/Depression
|
5.0%
1/20 • Number of events 1 • 6 months
Definition of AEs and SAEs per clinicaltrials.gov were used
|
|
Cardiac disorders
CHF symptoms
|
10.0%
2/20 • Number of events 3 • 6 months
Definition of AEs and SAEs per clinicaltrials.gov were used
|
|
Nervous system disorders
Sleep Apnea
|
5.0%
1/20 • Number of events 1 • 6 months
Definition of AEs and SAEs per clinicaltrials.gov were used
|
|
Blood and lymphatic system disorders
Hyperlipidemia
|
5.0%
1/20 • Number of events 1 • 6 months
Definition of AEs and SAEs per clinicaltrials.gov were used
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee Approval from St. Jude Medical prior to any publication.
- Publication restrictions are in place
Restriction type: OTHER